Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Vivace Therapeutics, Inc. See All Filings	D	2025-03-12 14:40:09 UTC
Amount To Be Raised $34,999,993 Associated Brokers / Dealers N/A CIK Number 0001630575 Filed Document 0001630575-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-03-12 14:40:09 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Vivace Therapeutics, Inc. See All Filings	D	2020-12-22 18:17:36 UTC
Amount To Be Raised $29,999,993 Associated Brokers / Dealers N/A CIK Number 0001630575 Filed Document 0001630575-20-000003 Exclusions or Exemptions 506b Accepted Date 2020-12-22 18:17:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Vivace Therapeutics, Inc. See All Filings	D/A	2018-05-01 16:42:45 UTC
Amount To Be Raised $24,999,998 Associated Brokers / Dealers N/A CIK Number 0001630575 Filed Document 0001630575-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-05-01 16:42:45 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Vivace Therapeutics, Inc. See All Filings	D	2017-05-18 11:35:40 UTC
Amount To Be Raised $24,999,998 Associated Brokers / Dealers N/A CIK Number 0001630575 Filed Document 0001630575-17-000003 Exclusions or Exemptions 506b Accepted Date 2017-05-18 11:35:40 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Vivace Therapeutics, Inc. See All Filings	D	2015-01-20 00:00:00 UTC
Amount To Be Raised $15,050,000 Associated Brokers / Dealers N/A CIK Number 0001630575 Filed Document 0001630575-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-01-20 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity